Subsequently, they further modified the GD2.CD28.CD3ζ-CAR by attaching an anti-CD73 single-chain variable fragment (scFv) through a cleavable, tumor-sensitive linker, creating the CD73 scFv-GD2.CD28.CD3ζ-CAR. Here, CD28 is linked to neoplasm.